Evidence map›Paper›PMID 42798769›Full record

ReviewFrontiers in bioengineering and biotechnology2026

CRISPR/Cas diagnostics for

Weijia Yi, Hongzhi Luo, Fukang Luo, Qianyi Li, Xiaoxue Huang, Qiujie Yu, Guozhen Deng, Shan Liu

Abstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Weijia Yi *West China Hospital Sichuan University Jintang Hospital, Jintang First People's Hospital, Chengdu, China.
Hongzhi Luo *West China Hospital Sichuan University Jintang Hospital, Jintang First People's Hospital, Chengdu, China.
Fukang LuoWest China Hospital Sichuan University Jintang Hospital, Jintang First People's Hospital, Chengdu, China.
Qianyi LiDepartment of Laboratory Medicine, Public Health Clinical Center of Chengdu, Chengdu, China.
Xiaoxue HuangDepartment of Laboratory Medicine, The Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, China.
Qiujie YuThe Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, China.
Guozhen DengDepartment of Neurology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Shan LiuGenetic Diseases Key Laboratory of Sichuan Province, Department of Medical Genetics, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimicrobial resistance-associated targetsCRISPR/CasCRKPhvKphypervirulence-associated markersKlebsiella pneumoniaerisk reporting

Identifiers

PMID42798769
PMCPMC13613015

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.